Picture of InMed Pharmaceuticals logo

INM — InMed Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Brief: Inmed Says Jonathan Tegge Will Assume Role Of Interim Chief Financial Officer Effective December 12

Dec 12 (Reuters) - InMed Pharmaceuticals Inc  INM.O :
    * INMED ANNOUNCES APPOINTMENT OF INTERIM CHIEF FINANCIAL
OFFICER
AND CHANGE OF AUDITOR
    * INMED PHARMACEUTICALS -JONATHAN TEGGE WILL ASSUME ROLE OF
INTERIM CHIEF FINANCIAL OFFICER FOR COMPANY EFFECTIVE DECEMBER
12, 2022

Source text for Eikon:  ID:nGNXCWCB9 
Further company coverage:  INM.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on InMed Pharmaceuticals

See all news